Nico Gagelmann/LinkedIn
Aug 22, 2026, 14:41
Nico Gagelmann: What is the Future for Patients with Myeloproliferative Neoplasms?
Nico Gagelmann, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“What is the future for patients with myeloproliferative neoplasms?
A snapshot from the episode of MYTHS & FACTS on Hematology and Cell Therapy with Claire Harrison.
Watch or listen to the full episode with lots more nuanced and deep insights on Youtube and on Spotify.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 11, 2026, 22:40Bahram Alamdary Badlou: Platelets as First Responders in Hemostasis, Immunity, and Inflammation
-
Oct 11, 2026, 22:22Vipin Singh: New Publication on Hippo-YAP Signaling and Platelet Activation
-
Oct 11, 2026, 22:21Trygve Berge: New AFNOR Paper on AF-related Stroke in Norway
-
Oct 11, 2026, 22:09Omar Alomari: Our New Publication on Apixaban vs Rivaroxaban for VTE
-
Oct 11, 2026, 21:22Shayan Roshan: Happy to Share Two Research Milestones in Trauma Care and Pancreatic Cancer
-
Oct 11, 2026, 21:16Chokri Ben Lamine: Anemia in Myelofibrosis – Multiple Mechanisms, Limited Responses
-
Oct 11, 2026, 21:03Carmela Walker: Supporting Warriors Living With SCD Through Dental Care and Advocacy
-
Oct 11, 2026, 21:00Rishdha Roshad: Intraoperative Cell Salvage – Turning Blood Loss into an Opportunity for Recovery
-
Oct 11, 2026, 20:59Anthony R. Sloan: Honored to Share Our Work at the 20th Midwest Platelet Conference